Loading…
Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker
Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed...
Saved in:
Published in: | Clinical cancer research 2004-03, Vol.10 (6), p.1984-1991 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593 |
---|---|
cites | cdi_FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593 |
container_end_page | 1991 |
container_issue | 6 |
container_start_page | 1984 |
container_title | Clinical cancer research |
container_volume | 10 |
creator | CHANG QI ZHU BLACKHALL, Fiona H TSAO, Ming-Sound PINTILIE, Melania IYENGAR, Pratibha NI LIU HO, James CHOMIAK, Taylor LAU, Davina WINTON, Timothy SHEPHERD, Frances A |
description | Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed to
evaluate Skp2 abnormalities and their prognostic value in non-small cell lung cancer (NSCLC).
Experimental Design: In total 16 NSCLC cell lines and 163 primary tumors were included in studies to measure Skp2 relative gene copy number, mRNA abundance, and protein level. The tumors were also evaluated for p27 protein expression level
and ras mutation. These values were correlated with the clinical and pathological features of the patients.
Results: Skp2 relative gene copy number aberrations were found in 88 and 65% of NSCLC cell lines and primary tumors, respectively. Overrepresentation
was especially common among squamous cell carcinoma (74%). Both gene copy overrepresentation (13%) and loss (35%) were found
in adenocarcinoma. Skp2 relative gene copy number was significantly correlated with mRNA and protein levels, but none of these were correlated with
p27 protein levels. Neither high Skp2 protein expression nor ras mutation was prognostically significant. In NSCLCs with ras mutation, however, high Skp2 protein expression was a significant independent poor prognostic marker.
Conclusion: There appears to be a synergistic interaction between high Skp2 protein expression and ras mutation with negative impact on the survival of NSCLC patients. |
doi_str_mv | 10.1158/1078-0432.CCR-03-0470 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71756874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71756874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593</originalsourceid><addsrcrecordid>eNpNkd1u1DAQhSMEoj_wCKC5AfWCFDuOY-dyFUFZafsjWq6tWcfZNd3YqZ1Q-jC8Kw67CG7GI_k7M_Y5WfaGknNKufxIiZA5KVlx3jRfc8JSL8iz7JhyLnJWVPx56v8yR9lJjN8JoSUl5cvsiHJSUkGr4-zX7f1QwIVxBho_PMHV1K9NgEUqAUfrXYRFmO_63juwDq68y2973O2gMamsJreBBoO2zvf4AdC1sBwjXP8wwfwcgonR7oV3U-9DhEc7biFghMtp_LMAlhEQbrwPcBP8xvk4Wg2XGO5NeJW96HAXzevDeZp9-_zprvmSr64vls1ilWsmyJhTXDNTMElYgVUtOatrrWXXSa275EpZU2wlQ226Fg2p1m1dcVEwiozqlvKanWbv93OH4B8mE0fV26jT_9AZP0UlqOCVFGUC-R7UwccYTKeGYHsMT4oSNeeiZs_V7LlKuSjC1JxL0r09LJjWvWn_qQ5BJODdAcCocdcFdNrG_zguqZDzoLM9t7Wb7aMNRulEprBMNCmF7fyOStFaluw3cROkyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71756874</pqid></control><display><type>article</type><title>Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker</title><source>Freely Accessible Journals</source><creator>CHANG QI ZHU ; BLACKHALL, Fiona H ; TSAO, Ming-Sound ; PINTILIE, Melania ; IYENGAR, Pratibha ; NI LIU ; HO, James ; CHOMIAK, Taylor ; LAU, Davina ; WINTON, Timothy ; SHEPHERD, Frances A</creator><creatorcontrib>CHANG QI ZHU ; BLACKHALL, Fiona H ; TSAO, Ming-Sound ; PINTILIE, Melania ; IYENGAR, Pratibha ; NI LIU ; HO, James ; CHOMIAK, Taylor ; LAU, Davina ; WINTON, Timothy ; SHEPHERD, Frances A</creatorcontrib><description>Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed to
evaluate Skp2 abnormalities and their prognostic value in non-small cell lung cancer (NSCLC).
Experimental Design: In total 16 NSCLC cell lines and 163 primary tumors were included in studies to measure Skp2 relative gene copy number, mRNA abundance, and protein level. The tumors were also evaluated for p27 protein expression level
and ras mutation. These values were correlated with the clinical and pathological features of the patients.
Results: Skp2 relative gene copy number aberrations were found in 88 and 65% of NSCLC cell lines and primary tumors, respectively. Overrepresentation
was especially common among squamous cell carcinoma (74%). Both gene copy overrepresentation (13%) and loss (35%) were found
in adenocarcinoma. Skp2 relative gene copy number was significantly correlated with mRNA and protein levels, but none of these were correlated with
p27 protein levels. Neither high Skp2 protein expression nor ras mutation was prognostically significant. In NSCLCs with ras mutation, however, high Skp2 protein expression was a significant independent poor prognostic marker.
Conclusion: There appears to be a synergistic interaction between high Skp2 protein expression and ras mutation with negative impact on the survival of NSCLC patients.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-03-0470</identifier><identifier>PMID: 15041716</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antineoplastic agents ; Base Sequence ; Biological and medical sciences ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - mortality ; Carcinoma, Non-Small-Cell Lung - pathology ; Cell Line, Tumor ; Chromosome Aberrations ; DNA Primers ; Female ; Gene Expression Regulation, Neoplastic - genetics ; Genes, ras - genetics ; Humans ; Lung Neoplasms - genetics ; Lung Neoplasms - mortality ; Lung Neoplasms - pathology ; Male ; Medical sciences ; Middle Aged ; Mutation ; Neoplasm Staging ; Pharmacology. Drug treatments ; Polymerase Chain Reaction - methods ; Prognosis ; S-Phase Kinase-Associated Proteins - genetics ; Survival Analysis ; Tumors</subject><ispartof>Clinical cancer research, 2004-03, Vol.10 (6), p.1984-1991</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593</citedby><cites>FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15581780$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15041716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHANG QI ZHU</creatorcontrib><creatorcontrib>BLACKHALL, Fiona H</creatorcontrib><creatorcontrib>TSAO, Ming-Sound</creatorcontrib><creatorcontrib>PINTILIE, Melania</creatorcontrib><creatorcontrib>IYENGAR, Pratibha</creatorcontrib><creatorcontrib>NI LIU</creatorcontrib><creatorcontrib>HO, James</creatorcontrib><creatorcontrib>CHOMIAK, Taylor</creatorcontrib><creatorcontrib>LAU, Davina</creatorcontrib><creatorcontrib>WINTON, Timothy</creatorcontrib><creatorcontrib>SHEPHERD, Frances A</creatorcontrib><title>Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed to
evaluate Skp2 abnormalities and their prognostic value in non-small cell lung cancer (NSCLC).
Experimental Design: In total 16 NSCLC cell lines and 163 primary tumors were included in studies to measure Skp2 relative gene copy number, mRNA abundance, and protein level. The tumors were also evaluated for p27 protein expression level
and ras mutation. These values were correlated with the clinical and pathological features of the patients.
Results: Skp2 relative gene copy number aberrations were found in 88 and 65% of NSCLC cell lines and primary tumors, respectively. Overrepresentation
was especially common among squamous cell carcinoma (74%). Both gene copy overrepresentation (13%) and loss (35%) were found
in adenocarcinoma. Skp2 relative gene copy number was significantly correlated with mRNA and protein levels, but none of these were correlated with
p27 protein levels. Neither high Skp2 protein expression nor ras mutation was prognostically significant. In NSCLCs with ras mutation, however, high Skp2 protein expression was a significant independent poor prognostic marker.
Conclusion: There appears to be a synergistic interaction between high Skp2 protein expression and ras mutation with negative impact on the survival of NSCLC patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic agents</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - mortality</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Cell Line, Tumor</subject><subject>Chromosome Aberrations</subject><subject>DNA Primers</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic - genetics</subject><subject>Genes, ras - genetics</subject><subject>Humans</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neoplasm Staging</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Prognosis</subject><subject>S-Phase Kinase-Associated Proteins - genetics</subject><subject>Survival Analysis</subject><subject>Tumors</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpNkd1u1DAQhSMEoj_wCKC5AfWCFDuOY-dyFUFZafsjWq6tWcfZNd3YqZ1Q-jC8Kw67CG7GI_k7M_Y5WfaGknNKufxIiZA5KVlx3jRfc8JSL8iz7JhyLnJWVPx56v8yR9lJjN8JoSUl5cvsiHJSUkGr4-zX7f1QwIVxBho_PMHV1K9NgEUqAUfrXYRFmO_63juwDq68y2973O2gMamsJreBBoO2zvf4AdC1sBwjXP8wwfwcgonR7oV3U-9DhEc7biFghMtp_LMAlhEQbrwPcBP8xvk4Wg2XGO5NeJW96HAXzevDeZp9-_zprvmSr64vls1ilWsmyJhTXDNTMElYgVUtOatrrWXXSa275EpZU2wlQ226Fg2p1m1dcVEwiozqlvKanWbv93OH4B8mE0fV26jT_9AZP0UlqOCVFGUC-R7UwccYTKeGYHsMT4oSNeeiZs_V7LlKuSjC1JxL0r09LJjWvWn_qQ5BJODdAcCocdcFdNrG_zguqZDzoLM9t7Wb7aMNRulEprBMNCmF7fyOStFaluw3cROkyQ</recordid><startdate>20040315</startdate><enddate>20040315</enddate><creator>CHANG QI ZHU</creator><creator>BLACKHALL, Fiona H</creator><creator>TSAO, Ming-Sound</creator><creator>PINTILIE, Melania</creator><creator>IYENGAR, Pratibha</creator><creator>NI LIU</creator><creator>HO, James</creator><creator>CHOMIAK, Taylor</creator><creator>LAU, Davina</creator><creator>WINTON, Timothy</creator><creator>SHEPHERD, Frances A</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040315</creationdate><title>Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker</title><author>CHANG QI ZHU ; BLACKHALL, Fiona H ; TSAO, Ming-Sound ; PINTILIE, Melania ; IYENGAR, Pratibha ; NI LIU ; HO, James ; CHOMIAK, Taylor ; LAU, Davina ; WINTON, Timothy ; SHEPHERD, Frances A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic agents</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - mortality</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Cell Line, Tumor</topic><topic>Chromosome Aberrations</topic><topic>DNA Primers</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic - genetics</topic><topic>Genes, ras - genetics</topic><topic>Humans</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neoplasm Staging</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Prognosis</topic><topic>S-Phase Kinase-Associated Proteins - genetics</topic><topic>Survival Analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHANG QI ZHU</creatorcontrib><creatorcontrib>BLACKHALL, Fiona H</creatorcontrib><creatorcontrib>TSAO, Ming-Sound</creatorcontrib><creatorcontrib>PINTILIE, Melania</creatorcontrib><creatorcontrib>IYENGAR, Pratibha</creatorcontrib><creatorcontrib>NI LIU</creatorcontrib><creatorcontrib>HO, James</creatorcontrib><creatorcontrib>CHOMIAK, Taylor</creatorcontrib><creatorcontrib>LAU, Davina</creatorcontrib><creatorcontrib>WINTON, Timothy</creatorcontrib><creatorcontrib>SHEPHERD, Frances A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHANG QI ZHU</au><au>BLACKHALL, Fiona H</au><au>TSAO, Ming-Sound</au><au>PINTILIE, Melania</au><au>IYENGAR, Pratibha</au><au>NI LIU</au><au>HO, James</au><au>CHOMIAK, Taylor</au><au>LAU, Davina</au><au>WINTON, Timothy</au><au>SHEPHERD, Frances A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2004-03-15</date><risdate>2004</risdate><volume>10</volume><issue>6</issue><spage>1984</spage><epage>1991</epage><pages>1984-1991</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed to
evaluate Skp2 abnormalities and their prognostic value in non-small cell lung cancer (NSCLC).
Experimental Design: In total 16 NSCLC cell lines and 163 primary tumors were included in studies to measure Skp2 relative gene copy number, mRNA abundance, and protein level. The tumors were also evaluated for p27 protein expression level
and ras mutation. These values were correlated with the clinical and pathological features of the patients.
Results: Skp2 relative gene copy number aberrations were found in 88 and 65% of NSCLC cell lines and primary tumors, respectively. Overrepresentation
was especially common among squamous cell carcinoma (74%). Both gene copy overrepresentation (13%) and loss (35%) were found
in adenocarcinoma. Skp2 relative gene copy number was significantly correlated with mRNA and protein levels, but none of these were correlated with
p27 protein levels. Neither high Skp2 protein expression nor ras mutation was prognostically significant. In NSCLCs with ras mutation, however, high Skp2 protein expression was a significant independent poor prognostic marker.
Conclusion: There appears to be a synergistic interaction between high Skp2 protein expression and ras mutation with negative impact on the survival of NSCLC patients.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15041716</pmid><doi>10.1158/1078-0432.CCR-03-0470</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-0432 |
ispartof | Clinical cancer research, 2004-03, Vol.10 (6), p.1984-1991 |
issn | 1078-0432 1557-3265 |
language | eng |
recordid | cdi_proquest_miscellaneous_71756874 |
source | Freely Accessible Journals |
subjects | Adult Aged Aged, 80 and over Antineoplastic agents Base Sequence Biological and medical sciences Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Cell Line, Tumor Chromosome Aberrations DNA Primers Female Gene Expression Regulation, Neoplastic - genetics Genes, ras - genetics Humans Lung Neoplasms - genetics Lung Neoplasms - mortality Lung Neoplasms - pathology Male Medical sciences Middle Aged Mutation Neoplasm Staging Pharmacology. Drug treatments Polymerase Chain Reaction - methods Prognosis S-Phase Kinase-Associated Proteins - genetics Survival Analysis Tumors |
title | Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T09%3A26%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Skp2%20Gene%20Copy%20Number%20Aberrations%20Are%20Common%20in%20Non-Small%20Cell%20Lung%20Carcinoma,%20and%20Its%20Overexpression%20in%20Tumors%20with%20ras%20Mutation%20Is%20a%20Poor%20Prognostic%20Marker&rft.jtitle=Clinical%20cancer%20research&rft.au=CHANG%20QI%20ZHU&rft.date=2004-03-15&rft.volume=10&rft.issue=6&rft.spage=1984&rft.epage=1991&rft.pages=1984-1991&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-03-0470&rft_dat=%3Cproquest_cross%3E71756874%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71756874&rft_id=info:pmid/15041716&rfr_iscdi=true |